The purpose of this study is to investigate if N-803, a new experimental drug that stimulates the immune system, is safe and tolerable when given alone and in combination with two new experimental drugs that are antibodies (natural proteins that the body makes in response to an infection) to HIV (the virus that causes AIDS), VRC07-523LS and 10-1074. This study will also look at how well HIV is controlled after stopping anti-HIV medications (also known as "ART") in persons who received N-803 alone or N-803 with VRC07-523LS and 10-1074.
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina (Statewide)
David Wohl
Medicine-Infectious Diseases
Clinical or Medical
Interventional
HIV/AIDS
21-0056